Medsteer
Medsteer SAS develops EasyTIVA, a patented closed-loop Total Intravenous Anesthesia platform that automates Propofol and Remifentanil dosing via real-time EEG-guided algorithms, serving hospitals, surgical centers, and anesthesiologists worldwide.
- Company typePrivate
- Founded2006
- HeadquartersForest Hills, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Medsteer does
Medsteer SAS is a private French medical technology company specializing in closed-loop anesthesia drug delivery systems. The company's flagship product, EasyTIVA, is a patented platform that automates the dosing of Propofol and Remifentanil during surgical procedures by using real-time EEG-based depth-of-anesthesia indices (BIS and spectral M-Entropy) as feedback to a proprietary control algorithm. EasyTIVA supports both induction and regulation phases and is designed for use across all patient types and all surgical procedures, validated across 25+ multicenter clinical trials and more than 15,000 patient inclusions since 2006 in 9 countries.
Medsteer operates with a small team (11-50 employees) under a dual-channel go-to-market model: direct sales to hospitals and surgical centers for EasyTIVA platform deployment, and technology licensing/integration partnerships with pharmaceutical and medical device companies seeking to embed EEG-guided closed-loop control into their own platforms. The company's technology integrates with third-party brain monitoring systems from Medtronic and GE Healthcare and uses standard syringe pumps within a closed-loop architecture. Pricing is not publicly disclosed and is likely quotation-based for institutional procurement.
In January 2026, Medsteer entered a strategic exclusive collaboration with Cyclerion Therapeutics to integrate its EEG-guided closed-loop control technology into Cyclerion's closed-loop anesthetic platform for CYC-126, an investigational therapy for treatment-resistant depression — a notable expansion of the core technology into psychiatric indications beyond surgical anesthesia. The company is also developing a reference design device as a next-generation tool for anesthesiologists, signaling a transition from a pure technology licensor toward a hardware-enabled medical device company.
Medsteer firmographics
Firmographics- Name
- Medsteer
- Legal name
- Medsteer SAS
- Website
- https://medsteer.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Medsteer SAS develops EasyTIVA, a patented closed-loop Total Intravenous Anesthesia platform that automates Propofol and Remifentanil dosing via real-time EEG-guided algorithms, serving hospitals, surgical centers, and anesthesiologists worldwide.
- Ownership category
- akta.pro rank
Medsteer industry classification
Industry- Product category
- Closed-Loop Anesthesia Delivery Systems
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Anesthesia & Airway Management Equipment (Workstations, Laryngoscopy, Ventilation adjuncts) (HLAHADAJ)
- akta.pro secondary industry
- Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)
Keywords
Where Medsteer is headquartered
LocationHeadquarters
- HQ city
- Forest Hills
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Medsteer business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Distribution channels2 records
Marketing channels2 records
Medsteer product offering
Product offeringCore offering
Medsteer sells the patented EasyTIVA technology platform, a closed-loop Total Intravenous Anesthesia (TIVA) system that fully automates the induction and regulation of Propofol and Remifentanil dosing during surgery. The platform uses a proprietary EEG-guided algorithm that ingests real-time depth-of-anesthesia index values (0–100) from compatible brain monitors and non-invasive forehead sensors, then drives standard syringe pumps in a closed-loop architecture to deliver precise drug amounts. The technology is targeted at hospitals, surgical centers, and anesthesiologists, and is also being licensed for integration into pharmaceutical platforms (e.g., Cyclerion's CYC-126).
Product overview
Medsteer is a technology provider in closed-loop anesthesia drug delivery systems. The company's primary product is EasyTIVA, a patented technology platform that automates Propofol and Remifentanil dosing guided by real-time EEG monitoring. EasyTIVA represents the core platform, while the company is also developing a reference design device as a next-generation tool for anesthesiologists. The technology has been validated through over 25 clinical trials with more than 15,000 patient inclusions since 2006.
Differentiator
Problem solved
Functional benefit
Brands
- EasyTIVA: Patented technology platform delivering full automation in the dosage of Propofol and Remifentanil for closed-loop total intravenous anesthesia, with real-time EEG-guided drug delivery.
Products and services
- EasyTIVA Patented closed-loop Total Intravenous Anesthesia (TIVA) technology platform that provides full automation in the dosage of Propofol and Remifentanil during surgery. The platform uses a proprietary EEG-guided algorithm that ingests real-time depth-of-anesthesia index values (0–100 scale) from compatible brain monitors and non-invasive disposable forehead sensors, then drives standard syringe pumps in a closed-loop architecture to deliver precise drug amounts during both induction and regulation phases. Validated for all patients and all surgery types and supported by compatibility with Medtronic and GE Healthcare brain monitor systems.
Companies that use Medsteer
Customer profileSegments2 records
Ideal customer profiles1 record
Medsteer technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability3 records
Feature4 records
Medsteer partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Cyclerion TherapeuticscoreStrategic exclusive collaboration to integrate Medsteer's EEG-guided closed-loop control technology into Cyclerion's closed-loop anesthetic platform for CYC-126, an investigational anesthetic-based therapy for treatment-resistant depression. Medsteer provides computational modules, control software, and datasets developed across 25 clinical settings and 9,000 patients. This partnership represents a significant expansion of Medsteer's technology into psychiatric applications beyond surgical anesthesia.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
Medsteer competitors and assessment
Company assessmentBroad incumbents
- GE HealthCare: GE Healthcare is a main supplier of brain monitoring systems compatible with EasyTIVA and offers comprehensive anesthesia delivery and patient monitoring solutions, making it both a partner and a broad incumbent in the same OR ecosystem.
- Medtronic: Medtronic supplies the BIS brain monitoring system used as input to EasyTIVA, but also markets broader perioperative and patient monitoring portfolios, positioning it as both a partner and a potential full-stack competitor in closed-loop OR automation.
- Drägerwerk: Dräger is a leading global supplier of anesthesia workstations, integrated patient monitoring, and OR IT, and could bundle competing closed-loop capabilities into its Perseus and similar anesthesia platforms over time.
- Edwards Lifesciences: Edwards provides hemodynamic monitoring used alongside anesthesia delivery in the OR and has explored closed-loop fluid and drug administration concepts, making it an adjacent incumbent with overlapping clinical use cases.
- Koninklijke Philips: Philips provides perioperative patient monitoring and integrated OR solutions overlapping with Medsteer's clinical environment, and has been investing in decision-support and AI-driven anesthesia analytics that could converge with closed-loop dosing.
- Becton Dickinson: BD offers infusion and medication management technologies used in surgical and ICU sedation settings, and competes in adjacent closed-loop and smart-pump categories relevant to Medsteer's dosing automation value proposition.
Direct peers
- Masimo: Masimo's SedLine EEG-based depth-of-anesthesia monitor competes directly with the Medtronic/GE monitors that EasyTIVA relies on, and Masimo increasingly integrates analytics into its own OR platform, making it the closest adjacent competitor in EEG-guided anesthesia.
- ICU Medical: ICU Medical (Smiths Medical infusion portfolio) supplies syringe pumps and infusion systems that are central to closed-loop drug delivery architectures like EasyTIVA, and is a direct adjacency in the closed-loop anesthesia technology stack.
Emerging players
- Mindray: Mindray provides patient monitoring and anesthesia delivery systems including EEG-based depth-of-anesthesia modules, and is rapidly expanding in emerging markets, representing a growing lower-cost competitor to EasyTIVA's positioning.
- Sedana Medical: Sedana Medical focuses on inhaled sedation in the ICU setting, an adjacent clinical use case to Medsteer's closed-loop IV anesthesia and sedation platform, with overlapping anesthesiology and critical care customer segments.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Medsteer social profiles
Digital presenceMedsteer financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medsteer leadership team
Management profileNumber of profiles
Profiles3 records
Medsteer funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medsteer M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medsteer
What does Medsteer do?
Medsteer sells the patented EasyTIVA technology platform, a closed-loop Total Intravenous Anesthesia (TIVA) system that fully automates the induction and regulation of Propofol and Remifentanil dosing during surgery. The platform uses a proprietary EEG-guided algorithm that ingests real-time depth-of-anesthesia index values (0–100) from compatible brain monitors and non-invasive forehead sensors, then drives standard syringe pumps in a closed-loop architecture to deliver precise drug amounts. The technology is targeted at hospitals, surgical centers, and anesthesiologists, and is also being licensed for integration into pharmaceutical platforms (e.g., Cyclerion's CYC-126).
Is Medsteer a public or private company?
Medsteer is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Medsteer founded?
Medsteer was founded in 2006. It employs 11 to 50 people.
Where is Medsteer based?
Medsteer is headquartered in Forest Hills, United States, in the North America region.
Who are Medsteer's main competitors?
Broad incumbents on record are GE HealthCare, Medtronic, Drägerwerk, Edwards Lifesciences, Koninklijke Philips and Becton Dickinson. Direct peers are Masimo and ICU Medical. Emerging players are Mindray and Sedana Medical.
Does Medsteer have an API?
No public API is recorded for Medsteer.
What industry is Medsteer in?
Medsteer's product category is Closed-Loop Anesthesia Delivery Systems. Its primary akta.pro industry code is HLAHADAJ, Anesthesia & Airway Management Equipment (Workstations, Laryngoscopy, Ventilation adjuncts), with a secondary code of HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring. Its NAICS code is 339112 and its SIC code is 3841.